Patents by Inventor Franceline Reynaud

Franceline Reynaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nanoparticulate prodrugs
    Patent number: 11642320
    Abstract: The present invention relates to anti-inflammatory drug formulation. Especially, this invention relates to corticosteroid prodrug nanoparticle. In a first aspect, this invention relates to a nanoparticle comprising a therapeutic agent and a surface coating material. The invention also relates to a process of manufacturing at least one nanoparticle of invention. The invention also relates to pharmaceutical composition and pharmaceutical kits.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: May 9, 2023
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS-SACLAY
    Inventors: Elias Fattal, Nicolas Tsapis, Mathilde Lorscheider, Romain Canioni, Franceline Reynaud
  • NANOPARTICULATE PRODRUGS
    Publication number: 20210275462
    Abstract: Disclosed is an anti-inflammatory drug formulation, especially a corticosteroid prodrug nanoparticle. In a first aspect, a nanoparticle includes a therapeutic agent and a surface coating material. Also disclosed are a process of manufacturing at least one nanoparticle, a pharmaceutical composition, and pharmaceutical kits.
    Type: Application
    Filed: September 20, 2017
    Publication date: September 9, 2021
    Inventors: Elias FATTAL, Nicolas TSAPIS, Mathilde LORSCHEIDER, Romain CANIONI, Franceline REYNAUD
  • Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract
    Patent number: 8951564
    Abstract: The present invention relates to a galenic form comprising particles capable of specifically adsorbing the undesirable molecules present in the digestive tract, to the method for preparing same and to the use thereof in particular for producing a medicine intended for preventing or treating undesirable effects linked to an imbalance of the intestinal and/or colonic flora that can result for example from treatment with antibiotics.
    Type: Grant
    Filed: September 22, 2010
    Date of Patent: February 10, 2015
    Assignee: Centre National de la Recherche Scientifique—CNRS—
    Inventors: Elias Fattal, Nicolas Tsapis, Franceline Reynaud
  • GALENIC FORM SUITABLE FOR ABSORBING, IN A SPECIFIC MANNER, THE UNDESIRABLE MOLECULES IN THE DIGESTIVE TRACT
    Publication number: 20120231084
    Abstract: The present invention relates to a galenic form comprising particles capable of specifically adsorbing the undesirable molecules present in the digestive tract, to the method for preparing same and to the use thereof in particular for producing a medicine intended for preventing or treating undesirable effects linked to an imbalance of the intestinal and/or colonic flora that can result for example from treatment with antibiotics.
    Type: Application
    Filed: September 22, 2010
    Publication date: September 13, 2012
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS
    Inventors: Elias Fattal, Nicolas Tsapis, Franceline Reynaud